4//SEC Filing
PRZYBYL ARTHUR 4
Accession 0001144204-19-015117
CIK 0001023024other
Filed
Mar 19, 8:00 PM ET
Accepted
Mar 20, 4:07 PM ET
Size
16.3 KB
Accession
0001144204-19-015117
Insider Transaction Report
Form 4
PRZYBYL ARTHUR
DirectorPresident and CEO
Transactions
- Sale
Common Stock
2019-03-18$63.53/sh−24,802$1,575,671→ 205,076 total - Exercise/Conversion
Stock Options
2019-03-18−9,052→ 38,448 totalExercise: $49.51Exp: 2027-03-30→ Common Stock (9,052 underlying) - Sale
Common Stock
2019-03-19$63.51/sh−2,823$179,289→ 205,076 total - Exercise/Conversion
Stock Options
2019-03-18−6,375→ 0 totalExercise: $33.00Exp: 2024-03-31→ Common Stock (6,375 underlying) - Exercise/Conversion
Stock Options
2019-03-18−9,375→ 18,750 totalExercise: $40.59Exp: 2026-04-06→ Common Stock (9,375 underlying) - Exercise/Conversion
Stock Options
2019-03-19−2,823→ 35,625 totalExercise: $49.51Exp: 2027-03-30→ Common Stock (2,823 underlying)
Footnotes (5)
- [F1]The shares were sold in multiple trades at prices ranging from $63.49 to $64.06. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. The reporting person owns 205,076 shares of the Issuer's common stock following the transaction, which is the same number of shares reported on his most recent prior filing.
- [F2]The shares were sold in multiple trades at prices ranging from $63.49 to $63.60. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. The reporting person owns 205,076 shares of the Issuer's common stock following the transaction, which is the same number of shares reported on his most recent prior filing.
- [F3]Option vests and are exercisable over a four year period beginning on the first anniversary of April 1, 2014.
- [F4]Option vests and are exercisable over a four year period beginning on the first anniversary of April 7, 2016.
- [F5]Option vests and are exercisable over a four year period beginning on the first anniversary of March 31, 2017.
Documents
Issuer
ANI PHARMACEUTICALS INC
CIK 0001023024
Entity typeother
Related Parties
1- filerCIK 0001268135
Filing Metadata
- Form type
- 4
- Filed
- Mar 19, 8:00 PM ET
- Accepted
- Mar 20, 4:07 PM ET
- Size
- 16.3 KB